all report title image

KIDNEY CANCER DRUGS MARKET ANALYSIS

Kidney Cancer Drugs Market, By Therapy: Targeted Therapy, Immunotherapy, and Chemotherapy, By Pharmacological Class: Angiogenesis Inhibitors, mTOR Inhibitors, Cytokines, and Others (Immune checkpoint inhibitors, CTLA-4 inhibitors, antimetabolites and others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jun 2024
Code : CMI2399
Pages :173
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Kidney cancer drugs Market Key Factors

To learn more about this report, request sample copy

Key Players Insights

Pfizer Inc.
Novartis AG
Bristol-Myers Squibb Company
Roche Holding AG (Genentech, Inc.)
Bayer AG
Exelixis, Inc.
Merck & Co., Inc.
Eisai Co., Ltd.
Aveo Pharmaceuticals
AstraZeneca PLC
Ipsen Biopharmaceuticals, Inc.
GlaxoSmithKline plc
Abbott Laboratories Source
Amgen Inc.
Calithera Biosciences, Inc.
Active Biotech
Immatics Biotechnologies GmbH
Karyopharm Therapeutics

Kidney Cancer Drugs Market Report Snapshots

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Press Release

Kidney Cancer Drugs Market to Surpass US$ 10.31 Bn by 2031

Credibility and Certifications

ESOMAR

DUNS Registered

Clutch

DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.